Squamous cell cancer is one of the most common forms of skin cancer that tends to occur simultaneously in multiple organs of the body.

Consequently, an international team of experts led by Professor Stephen Jane along with Dr. Charbel Darido of Monash University has claimed to discover a gene that can play a role for protecting people from squamous cell cancer and explained that the gene named as Grhl3 can halt the cell proliferation whereas its absence is likely to cause squamous cell cancer. In addition, the expert team has also notified to acknowledge no Grhl3 gene in squamous cell cancer that can also affect other tissues as well can cause head and neck cancers.

"This means that a number of the usual hurdles in getting therapies to trial have already been cleared, so patients could be reaping the benefits of this research in five years”, explained Professor Stephen Jane while insisting that the drug has enough potential to show satisfactory results for SCC treatment . The drug is in clinical trials for estimating efficiency on other form of cancers.

As per the figures retrieved from the Cancer Council Australia, two out of three Australians is likely to suffer a skin cancer diagnosis, before celebrating 70th birthday, along with SCC as one of the most common cancer forms.

Usually, the SCC tends to originate from the cells lining body cavities and therefore more likely to increase its spell to the skin, lips, mouth, oesophagus, urinary bladder, prostate, lung, vagina and cervix.

Experts have expressed confidence that the research findings will surely help the experts to develop needed medications accordingly and claimed that there are several measures for increasing the gene that can offer protection against terrible skin cancer that affects countless people, across the globe.